Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue s7, 2014, Pages 35-39

  Menon, Usha ^a   Talaat, Ahmed ^a   Rosenthal, Adam N ^a   MacDonald, Nicola D ^a   Jeyerajah, Arjun R ^a   Skates, Steven J ^b   Sibley, Karen ^a   Oram, David H ^a   Jacobs, Ian J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CANCER REGISTRY; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORPHOLOGY; OVARY CANCER; POSTMENOPAUSE; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; BLOOD; EARLY DIAGNOSIS; EPIDEMIOLOGY; EVALUATION STUDY; MASS SCREENING; MIDDLE AGED; OVARY; OVARY TUMOR; PATHOLOGY; PREVALENCE; PROCEDURES; PROGNOSIS; RISK FACTOR; UNITED KINGDOM;

CA-125 ANTIGEN; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LONDON; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84919473991     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13211     Document Type: Article

References (14)

1. Campbell S. Bhan V. Royston P. Whitehead ML Collins WP. Transabdominal ultrasound screening for early ovarian cancer. BMJ 1989; 299: 1363-1367.
2. Bourne TH, Campbell S, Reynolds KM et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ 1993; 306: 1025-1029.
3. Van Nagell JR Jr. Gallion HH, Pavlik El, DePriest PD. Ovarian cancer screening. Cancer 1995; 76 (Suppi): 2086-2091.
4. Kurjak A, Shalan H, Kupesic S et al. An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography. J Ultrasound Med 1994; 13: 295-301.
5. Jacobs I, Stabile I, Bridges I et al. Multimodal approach to screening for ovarian cancer. Lance: 1988; 1: 268-271.
6. Jacobs I, Davies AP, Bridges I et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ 1993; 306: 1030-1034.
7. Adonakis GL, Paraskevaidis E, Tsiga S, Seferiadis K, Lolis DR A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstet Gynecol Reprod Blot 1996; 65: 221-225.
8. Rosenthal A, Jacobs I. Ovarian cancer screening. Semin Oncol 1998; 25: 315-325.
9. Jacobs U, Skates SJ. MacDonald N et al. A pilot randomised control trial of ovarian cancer screening. Lancet 1999; 353: 1207-1210.
10. Menon U, Talaat A, Jeyerajah AR et al. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation. BriCancer 1999; 80: 1644-1647.
11. Campbell S, Goessens L, Goswamy R, Whitehead M. Real-time ultrasonography for determination of ovarian morphology and volume. A possible early screening test for ovarian cancer? Lncet 1982; 1: 425-426.
12. MacDonald N, Sibley K, Rosenthal A et al. A comparison of National Cancer Registry and direct follow-up in the ascertainment of ovarian cancer. BrJ Cancer 1999; 80: 1826-1827.
13. Bailey CL, Ueland FR, Land GL et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 1998; 69: 3-7.
14. Skates SJ, Xu FJ, Yu YH et al. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumour markers. Cancer 1995; 76 (Suppi): 2004-2010.